Comparison of Successful and Unsuccessful Cases of New Drug Approvals Based on the International Council on Harmonization E5 Guidelines in Japan
Gespeichert in:
| Veröffentlicht in: | Clinical pharmacology in drug development 2021-05, Vol.10 (5), p.434-439 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 439 |
|---|---|
| container_issue | 5 |
| container_start_page | 434 |
| container_title | Clinical pharmacology in drug development |
| container_volume | 10 |
| creator | Asada, Ryuta Shimizu, Shinobu Nakamura, Harumasa Ono, Shunsuke Yamaguchi, Takuhiro |
| description | |
| doi_str_mv | 10.1002/cpdd.942 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2507668190</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2520226306</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3102-13a7b5a6351c95f7ac3e86489c3e5923abe0ce3eafe5e20723a539bb146d89fb3</originalsourceid><addsrcrecordid>eNp1kctKxTAQhoMoKir4BBJw46aay2naLrXneENUUMFdSdOpRtqkJieKPoWPbOoVBLOZMPPNB8OP0CYlu5QQtqeGptktJmwBrTIqSJKJSb748-e3K2jD-wcSnyCU0skyWuE8yzMi2Cp6K20_SKe9Ndi2-CooBd63ocPSNPjG-N9GKT34ETqHZzx14Q7vD4OzT7Lz-CDOGhwd83vAJ2YOzsi5tkbGNRuM0t04PJaut0a_fozwLMVHQTfQaRO92uBTOUizjpbaaISNr7qGbg5n1-VxcnZxdFLunyWKU8ISymVWp1LwlKoibTOpOOTx8CLWtGBc1kAUcJAtpMBIFjspL-qaTkSTF23N19DOpzee8BjAz6teewVdJw3Y4CuWkkyInBYkott_0Acb4oHdSDHCmOBE_AqVs947aKvB6V66l4qSagyqGoOqYlAR3foShrqH5gf8jiUCySfwrDt4-VdUlZfT6Sh8B9EanTQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2520226306</pqid></control><display><type>article</type><title>Comparison of Successful and Unsuccessful Cases of New Drug Approvals Based on the International Council on Harmonization E5 Guidelines in Japan</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Asada, Ryuta ; Shimizu, Shinobu ; Nakamura, Harumasa ; Ono, Shunsuke ; Yamaguchi, Takuhiro</creator><creatorcontrib>Asada, Ryuta ; Shimizu, Shinobu ; Nakamura, Harumasa ; Ono, Shunsuke ; Yamaguchi, Takuhiro</creatorcontrib><identifier>ISSN: 2160-763X</identifier><identifier>EISSN: 2160-7648</identifier><identifier>DOI: 10.1002/cpdd.942</identifier><identifier>PMID: 33787062</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>bridging strategy ; clinical study ; Drug Approval - statistics & numerical data ; drug development ; Drug Development - methods ; Drug Industry - methods ; drug lag ; Guidelines as Topic ; Humans ; Internationality ; Japan ; new drug application</subject><ispartof>Clinical pharmacology in drug development, 2021-05, Vol.10 (5), p.434-439</ispartof><rights>2021, The American College of Clinical Pharmacology</rights><rights>American College of Clinical Pharmacology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3102-13a7b5a6351c95f7ac3e86489c3e5923abe0ce3eafe5e20723a539bb146d89fb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcpdd.942$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcpdd.942$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33787062$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Asada, Ryuta</creatorcontrib><creatorcontrib>Shimizu, Shinobu</creatorcontrib><creatorcontrib>Nakamura, Harumasa</creatorcontrib><creatorcontrib>Ono, Shunsuke</creatorcontrib><creatorcontrib>Yamaguchi, Takuhiro</creatorcontrib><title>Comparison of Successful and Unsuccessful Cases of New Drug Approvals Based on the International Council on Harmonization E5 Guidelines in Japan</title><title>Clinical pharmacology in drug development</title><addtitle>Clin Pharmacol Drug Dev</addtitle><subject>bridging strategy</subject><subject>clinical study</subject><subject>Drug Approval - statistics & numerical data</subject><subject>drug development</subject><subject>Drug Development - methods</subject><subject>Drug Industry - methods</subject><subject>drug lag</subject><subject>Guidelines as Topic</subject><subject>Humans</subject><subject>Internationality</subject><subject>Japan</subject><subject>new drug application</subject><issn>2160-763X</issn><issn>2160-7648</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctKxTAQhoMoKir4BBJw46aay2naLrXneENUUMFdSdOpRtqkJieKPoWPbOoVBLOZMPPNB8OP0CYlu5QQtqeGptktJmwBrTIqSJKJSb748-e3K2jD-wcSnyCU0skyWuE8yzMi2Cp6K20_SKe9Ndi2-CooBd63ocPSNPjG-N9GKT34ETqHZzx14Q7vD4OzT7Lz-CDOGhwd83vAJ2YOzsi5tkbGNRuM0t04PJaut0a_fozwLMVHQTfQaRO92uBTOUizjpbaaISNr7qGbg5n1-VxcnZxdFLunyWKU8ISymVWp1LwlKoibTOpOOTx8CLWtGBc1kAUcJAtpMBIFjspL-qaTkSTF23N19DOpzee8BjAz6teewVdJw3Y4CuWkkyInBYkott_0Acb4oHdSDHCmOBE_AqVs947aKvB6V66l4qSagyqGoOqYlAR3foShrqH5gf8jiUCySfwrDt4-VdUlZfT6Sh8B9EanTQ</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Asada, Ryuta</creator><creator>Shimizu, Shinobu</creator><creator>Nakamura, Harumasa</creator><creator>Ono, Shunsuke</creator><creator>Yamaguchi, Takuhiro</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>202105</creationdate><title>Comparison of Successful and Unsuccessful Cases of New Drug Approvals Based on the International Council on Harmonization E5 Guidelines in Japan</title><author>Asada, Ryuta ; Shimizu, Shinobu ; Nakamura, Harumasa ; Ono, Shunsuke ; Yamaguchi, Takuhiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3102-13a7b5a6351c95f7ac3e86489c3e5923abe0ce3eafe5e20723a539bb146d89fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>bridging strategy</topic><topic>clinical study</topic><topic>Drug Approval - statistics & numerical data</topic><topic>drug development</topic><topic>Drug Development - methods</topic><topic>Drug Industry - methods</topic><topic>drug lag</topic><topic>Guidelines as Topic</topic><topic>Humans</topic><topic>Internationality</topic><topic>Japan</topic><topic>new drug application</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Asada, Ryuta</creatorcontrib><creatorcontrib>Shimizu, Shinobu</creatorcontrib><creatorcontrib>Nakamura, Harumasa</creatorcontrib><creatorcontrib>Ono, Shunsuke</creatorcontrib><creatorcontrib>Yamaguchi, Takuhiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical pharmacology in drug development</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Asada, Ryuta</au><au>Shimizu, Shinobu</au><au>Nakamura, Harumasa</au><au>Ono, Shunsuke</au><au>Yamaguchi, Takuhiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of Successful and Unsuccessful Cases of New Drug Approvals Based on the International Council on Harmonization E5 Guidelines in Japan</atitle><jtitle>Clinical pharmacology in drug development</jtitle><addtitle>Clin Pharmacol Drug Dev</addtitle><date>2021-05</date><risdate>2021</risdate><volume>10</volume><issue>5</issue><spage>434</spage><epage>439</epage><pages>434-439</pages><issn>2160-763X</issn><eissn>2160-7648</eissn><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>33787062</pmid><doi>10.1002/cpdd.942</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2160-763X |
| ispartof | Clinical pharmacology in drug development, 2021-05, Vol.10 (5), p.434-439 |
| issn | 2160-763X 2160-7648 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2507668190 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | bridging strategy clinical study Drug Approval - statistics & numerical data drug development Drug Development - methods Drug Industry - methods drug lag Guidelines as Topic Humans Internationality Japan new drug application |
| title | Comparison of Successful and Unsuccessful Cases of New Drug Approvals Based on the International Council on Harmonization E5 Guidelines in Japan |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T02%3A22%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20Successful%20and%20Unsuccessful%20Cases%20of%20New%20Drug%20Approvals%20Based%20on%20the%20International%20Council%20on%20Harmonization%20E5%20Guidelines%20in%20Japan&rft.jtitle=Clinical%20pharmacology%20in%20drug%20development&rft.au=Asada,%20Ryuta&rft.date=2021-05&rft.volume=10&rft.issue=5&rft.spage=434&rft.epage=439&rft.pages=434-439&rft.issn=2160-763X&rft.eissn=2160-7648&rft_id=info:doi/10.1002/cpdd.942&rft_dat=%3Cproquest_cross%3E2520226306%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2520226306&rft_id=info:pmid/33787062&rfr_iscdi=true |